Evidence map›Paper›PMID 24361630›Full record

ReviewAIDS (London, England)2013

Linkage, initiation and retention of children in the antiretroviral therapy cascade: an overview.

B Ryan Phelps, Saeed Ahmed, Anouk Amzel, Mamadou O Diallo, Troy Jacobs, Scott E Kellerman, Maria H Kim, Nandita Sugandhi, Melanie Tam, Megan Wilson-Jones and 1 more

Abstract readReview
In one paragraph

Review in AIDS (London, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

B Ryan PhelpsaUnited States Agency for International Development, Washington, District of Columbia bBaylor College of Medicine, Houston, Texas cUnited States Agency for International Development, Washington, District of Columbia dCenters for Disease Control and Prevention, Atlanta, Georgia eManagement Sciences for Health, Washington, District of Columbia fBaylor College of Medicine, Houston, Texas gClinton Health Access Initiative, New York, New York hLiverpool School of Tropical Medicine, UK. *B. Ryan Phelps, Saeed Ahmed, Anouk Amzel, Mamadou O. Diallo, Troy Jacobs, Scott E. Kellerman, Maria H. Kim, Nandita Sugandhi, and Melanie Tam contributed equally to the writing of the article.
Saeed Ahmed
Anouk Amzel
Mamadou O Diallo
Troy Jacobs
Scott E Kellerman
Maria H Kim
Nandita Sugandhi
Melanie Tam
Megan Wilson-Jones
Child Survival Working Group of the Interagency Task Team on the Prevention, Treatment of HIV infection in Pregnant Women, Mothers, Child

Funding

Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI LEWIS, DOROTHY E. · 1994 to 2015
$21.7M
Improving prevention of mother-to-child HIV transmission outcomes in MalawiK01TW009644 · FIC · BAYLOR COLLEGE OF MEDICINE · PI KIM, MARIA HYOUN · 2013 to 2017
$663k
FIC NIH HHS K01 TW009644NIAID NIH HHS P30 AI036211
6 · The paper itself

Abstract

In 2012, there were an estimated 2 million children in need of antiretroviral therapy (ART) in the world, but ART is still reaching fewer than 3 in 10 children in need of treatment. [1, 7] As more HIV-infected children are identified early and universal treatment is initiated in children under 5 regardless of CD4, the success of pediatric HIV programs will depend on our ability to link children into care and treatment programs, and retain them in those services over time. In this review, we summarize key individual, institutional, and systems barriers to diagnosing children with HIV, linking them to care and treatment, and reducing loss to follow-up (LTFU). We also explore how linkage and retention can be optimally measured so as to maximize the impact of available pediatric HIV care and treatment services.

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsCD4 Lymphocyte CountChild, PreschoolDelivery of Health Care, IntegratedHealthcare DisparitiesHealth PromotionHIV InfectionsHumansInfantInfant, NewbornLong-Term CareLost to Follow-UpPatient ComplianceWorld Health OrganizationAnti-HIV AgentsAnti-Retroviral Agents

Identifiers

PMID24361630
PMCPMC4124132

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.